Morpho-functional comparison of differentiation protocols to create iPSC-derived cardiomyocytes

ABSTRACT Cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) offer an attractive platform for cardiovascular research. Patient-specific iPSC-CMs are very useful for studying disease development, and bear potential for disease diagnostics, prognosis evaluation and development of personalized treatment. Several monolayer-based serum-free protocols have been described for the differentiation of iPSCs into cardiomyocytes, but data on their performance are scarce. In this study, we evaluated two protocols that are based on temporal modulation of the Wnt/β-catenin pathway for iPSC-CM differentiation from four iPSC lines, including two control individuals and two patients carrying an SCN5A mutation. The SCN5A gene encodes the cardiac voltage-gated sodium channel (Nav1.5) and loss-of-function mutations can cause the cardiac arrhythmia Brugada syndrome. We performed molecular characterization of the obtained iPSC-CMs by immunostaining for cardiac specific markers and by expression analysis of selected cardiac structural and ionic channel protein-encoding genes with qPCR. We also investigated cell growth morphology, contractility and survival of the iPSC-CMs after dissociation. Finally, we performed electrophysiological characterization of the cells, focusing on the action potential (AP) and calcium transient (CT) characteristics using patch-clamping and optical imaging, respectively. Based on our comprehensive morpho-functional analysis, we concluded that both tested protocols result in a high percentage of contracting CMs. Moreover, they showed acceptable survival and cell quality after dissociation (>50% of cells with a smooth cell membrane, possible to seal during patch-clamping). Both protocols generated cells presenting with typical iPSC-CM AP and CT characteristics, although one protocol (that involves sequential addition of CHIR99021 and Wnt-C59) rendered iPSC-CMs, which were more accessible for patch-clamp and calcium transient experiments and showed an expression pattern of cardiac-specific markers more similar to this observed in human heart left ventricle samples.

[1]  B. Loeys,et al.  iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives , 2021, International journal of molecular sciences.

[2]  I. Kopljar,et al.  The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells , 2021, Channels.

[3]  H. Heidbuchel,et al.  Clinical characterization of the first Belgian SCN5A founder mutation cohort. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  Jussi T. Koivumäki,et al.  hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells , 2020, Cells.

[5]  Stefano Severi,et al.  All-Optical Electrophysiology Refines Populations of In Silico Human iPSC-CMs for Drug Evaluation , 2020, Biophysical journal.

[6]  I. Kopljar,et al.  Pharmacological Profile of the Sodium Current in Human Stem Cell-Derived Cardiomyocytes Compares to Heterologous Nav1.5+β1 Model , 2019, Front. Pharmacol..

[7]  Jianyi(Jay) Zhang,et al.  Deciphering Role of Wnt Signalling in Cardiac Mesoderm and Cardiomyocyte Differentiation from Human iPSCs: Four-dimensional control of Wnt pathway for hiPSC-CMs differentiation , 2019, Scientific Reports.

[8]  M. Ackerman,et al.  MRAS Variants Cause Cardiomyocyte Hypertrophy in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2019, Circulation: Genomic and Precision Medicine.

[9]  P. Taimen,et al.  Modeling of LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cells , 2019, Cells.

[10]  Vivek Garg,et al.  Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists , 2018, Circulation research.

[11]  K. Aalto-Setälä,et al.  Simultaneous recordings of action potentials and calcium transients from human induced pluripotent stem cell derived cardiomyocytes , 2018, Biology Open.

[12]  S. Cambridge,et al.  Improving electrical properties of iPSC-cardiomyocytes by enhancing Cx43 expression. , 2018, Journal of molecular and cellular cardiology.

[13]  K. Chojnacka,et al.  The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin , 2018, Cell transplantation.

[14]  Marjan Gucek,et al.  Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes , 2018, Stem cell reports.

[15]  Xin Li,et al.  Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes , 2018, Stem cells international.

[16]  B. Knollmann,et al.  Thyroid and Glucocorticoid Hormones Promote Functional T-Tubule Development in Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes , 2017, Circulation research.

[17]  J Hyttinen,et al.  Simultaneous Measurement of Contraction and Calcium Transients in Stem Cell Derived Cardiomyocytes , 2017, Annals of Biomedical Engineering.

[18]  T. V. van Veen,et al.  The immature electrophysiological phenotype of iPSC‐CMs still hampers in vitro drug screening: Special focus on IK1 , 2017, Pharmacology & therapeutics.

[19]  C. Yin,et al.  Comparative Gene Expression Analyses Reveal Distinct Molecular Signatures between Differentially Reprogrammed Cardiomyocytes. , 2017, Cell reports.

[20]  M. Pruniaux,et al.  Differential Sarcomere and Electrophysiological Maturation of Human iPSC-Derived Cardiac Myocytes in Monolayer vs. Aggregation-Based Differentiation Protocols , 2017, International journal of molecular sciences.

[21]  Li Pang,et al.  MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity? , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[22]  Joseph M Metzger,et al.  Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. , 2016, Biochimica et biophysica acta.

[23]  Kenji Yasuda,et al.  A distribution analysis of action potential parameters obtained from patch-clamped human stem cell-derived cardiomyocytes. , 2016, Journal of pharmacological sciences.

[24]  José Jalife,et al.  Extracellular Matrix–Mediated Maturation of Human Pluripotent Stem Cell–Derived Cardiac Monolayer Structure and Electrophysiological Function , 2016, Circulation. Arrhythmia and electrophysiology.

[25]  Jonathan E. Hempel,et al.  Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. , 2015, Circulation research.

[26]  Charles C Hong,et al.  Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories. , 2015, Journal of molecular and cellular cardiology.

[27]  A. V. van Ginneken,et al.  Ion channelopathies in human induced pluripotent stem cell derived cardiomyocytes: a dynamic clamp study with virtual IK1 , 2015, Front. Physiol..

[28]  J. Gibson,et al.  Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents. , 2014, Journal of pharmacological and toxicological methods.

[29]  K. Boheler,et al.  High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. , 2014, Journal of visualized experiments : JoVE.

[30]  P. Alves,et al.  Combining Hypoxia and Bioreactor Hydrodynamics Boosts Induced Pluripotent Stem Cell Differentiation Towards Cardiomyocytes , 2014, Stem Cell Reviews and Reports.

[31]  H. Ruohola-Baker,et al.  Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells. , 2014, Journal of molecular and cellular cardiology.

[32]  B. Cui,et al.  Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes , 2014, Nature methods.

[33]  S. Priori,et al.  Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype , 2014, Circulation.

[34]  Kumaraswamy Nanthakumar,et al.  Biowire: a New Platform for Maturation of Human Pluripotent Stem Cell Derived Cardiomyocytes Pubmed Central Canada , 2022 .

[35]  Sean P. Palecek,et al.  Insulin Inhibits Cardiac Mesoderm, Not Mesendoderm, Formation During Cardiac Differentiation of Human Pluripotent Stem Cells and Modulation of Canonical Wnt Signaling Can Rescue This Inhibition , 2013, Stem cells.

[36]  Sean P. Palecek,et al.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions , 2012, Nature Protocols.

[37]  Norio Nakatsuji,et al.  A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. , 2012, Cell reports.

[38]  H. Calkins,et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.

[39]  G. Lyons,et al.  Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells: The Matrix Sandwich Method , 2012, Circulation research.

[40]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[41]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[42]  Laura Iop,et al.  Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia , 2012, EMBO molecular medicine.

[43]  J. Paavola,et al.  Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. , 2011, Journal of molecular and cellular cardiology.

[44]  Xuan Yuan,et al.  A Universal System for Highly Efficient Cardiac Differentiation of Human Induced Pluripotent Stem Cells That Eliminates Interline Variability , 2011, PloS one.

[45]  M. Seyfarth,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010 .

[46]  P. Van Oostveldt,et al.  High content image cytometry in the context of subnuclear organization , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[47]  Lawrence Lum,et al.  Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer , 2008, Nature chemical biology.

[48]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[49]  R. Passier,et al.  Insulin Redirects Differentiation from Cardiogenic Mesoderm and Endoderm to Neuroectoderm in Differentiating Human Embryonic Stem Cells , 2008, Stem cells.

[50]  E. Kroon,et al.  Efficient differentiation of human embryonic stem cells to definitive endoderm , 2005, Nature Biotechnology.

[51]  L Gepstein,et al.  Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. , 2001, The Journal of clinical investigation.

[52]  Yan Zhuge,et al.  Induced Pluripotent Stem Cell – Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome , 2016 .

[53]  N. Terada,et al.  A practical guide to induced pluripotent stem cell research using patient samples , 2015, Laboratory Investigation.

[54]  I. Karakikes,et al.  Induced Pluripotent Stem Cell–Derived Cardiomyocytes: A New and Versatile Human In Vitro Cardiomyocyte Model Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes Insights Into Molecular, Cellular, and Functional Phenotypes , 2015 .

[55]  Qinlian Zhou,et al.  Electronic "expression" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. , 2013, Heart rhythm.

[56]  R. Dolmetsch,et al.  Using iPS cells to investigate cardiac phenotypes in patients with Timothy Syndrome , 2012 .

[57]  H. Tan,et al.  Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. , 2009, Cardiovascular research.